Ruo-yu Wang

Shanghai, 200438, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Retraction: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.

Retraction: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.

Journal: Cancer research
Published: May 15, 2026

Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.

Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.

Journal: Gene
Published: September 25, 2018

Long non-coding RNA DILC suppresses cell proliferation and metastasis in colorectal cancer.

Long non-coding RNA DILC suppresses cell proliferation and metastasis in colorectal cancer.

Journal: Gene
Published: November 18, 2017

Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: May 31, 2017

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.

Journal: Nature communications
Published: November 09, 2016

Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.

Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.

Journal: Gastroenterology
Published: August 12, 2016

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.

Journal: Nature communications
Published: January 29, 2016

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.

Journal: Oncotarget
Published: January 06, 2016

Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection.

Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection.

Journal: Oncotarget
Published: December 22, 2015

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy.

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy.

Journal: Medicine
Published: October 09, 2015

PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.

PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.

Journal: Journal of hepatology
Published: October 04, 2014

RETRACTED: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.

RETRACTED: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.

Journal: Cancer research
Published: June 04, 2014
Showing 1-12 of 18

Last Updated: 09/26/2026